|
| Saturday, February 4, 2023 |
|
|
亞太地區細胞與基因研究：Novotech 的增長速度比世界其它地區快 50% |
| Novotech 是亞太地區領先的生物技術專家 CRO 和亞太地區細胞與基因治療臨床試驗卓越獎的獲得者，該公司表示該地區細胞與基因治療試驗的數量增長速度比世界其它地區快 50%。大多數試驗都在腫瘤學領域，特別是針對血癌、病毒感染和實體瘤。 more info >> |
|
| Friday, February 3, 2023 |
|
|
Asia Pacific Cell & Gene Research Growing 50% Faster than ROW |
| Novotech, the leading Asia Pacific focused biotech specialist CRO and recipient of the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence award, said the number of cell & gene therapy trials in the region was growing 50% faster than ROW. The majority of trials are in oncology, specifically for blood cancers, viral infections, and solid tumors. more info >> |
|
| Thursday, January 12, 2023 |
|
|
Novotech Acquires US-based Drug Development Consulting Firm, CBR International |
| Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR International, a global product development, clinical oversight and strategic regulatory operations group. more info >> |
|
|
Novotech Acquires European CRO, Strengthens Global Operations |
| Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations across the continent. The acquisition is part of Novotech's global expansion program. EastHORN was established in 2004 and has over 250 employees. more info >> |
|
|
Novotech 收购美国药物开发咨询公司 CBR International |
| 太地区领先的生物技术 CRO Novotech 今天宣布收购全球产品开发、临床监督和战略监管运营集团 CBR International。 more info >> |
|
|
Novotech 收購美國藥物開發諮詢公司 CBR International |
| 太地區領先的生物技術 CRO Novotech 今天宣布收購全球產品開發、臨床監督和戰略監管運營集團 CBR International。 more info >> |
|
|
Novotech 收购欧洲 CRO——加强全球运营 |
| Novotech 今天宣布收购 EastHORN，这是一家欧洲 CRO，在欧洲大陆多个具有重要战略意义的地点拥有临床、医疗和监管专业知识。此次收购是 Novotech 全球扩张计划的一部分。 EastHORN 成立于 2004 年，拥有 250 多名员工。 more info >> |
|
|
Novotech 收購歐洲 CRO——加強全球運營 |
| Novotech 今天宣布收購 EastHORN，這是一家歐洲 CRO，在歐洲大陸多個具有重要戰略意義的地點擁有臨床、醫療和監管專業知識。此次收購是 Novotech 全球擴張計劃的一部分。 EastHORN 成立於 2004 年，擁有 250 多名員工。 more info >> |
|
|
노보텍, 미국 기반의 의약품 개발 컨설팅 회사인 CBR 인터내셔널 인수 |
| 아시아 태평양 중심의 선도적인 생명공학 CRO인 노보텍(Novotech)은 오늘 글로벌 제품 개발과 임상 감독, 전략적 규제 운영 그룹인 CBR 인터내셔널을 인수했다고 발표했습니다. more info >> |
|
|
노보텍, 유럽 CRO 인수 - 글로벌 운영 강화 |
| 노보텍은 오늘 유럽의 전략적으로 중요한 여러 위치에서 임상, 의료, 규제 전문성을 갖춘 유럽 CRO인 이스트혼(EastHORN)을 인수했다고 발표했습니다. 이번 인수는 노보텍의 글로벌 확장 프로그램의 일환입니다. 2004년에 설립된 이스트혼에는 250명 이상의 직원들이 있습니다. more info >> |
|
|
|
|
